Delivery Order SPE2DB22D1106-SPE2DB25FEZT8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Icosapent Ethyl 1 Gram Capsules in quantities of 120 units, with a ceiling value of $2,212.37. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $1,118.97. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an...
- This is a $1,037.55 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product. The order has a firm fixed price and an ultimate completion date of August 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Icosapent Ethyl 1 Gram Capsule 120s, with a ceiling value of $2,053.92 and a completion date of June 10, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,904.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical (DLA TPMED) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,579.30 contract is for the delivery of 120-count 1-gram capsules of the prescription drug icosapent ethyl. The contract has a completion date of May 5, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZT8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,281.58 to AmerisourceBergen Drug Corp for Icosapent Ethyl 1 gram capsules (120-count package), with an ultimate completion date of July 28, 2025. This non-competitive, competitively awarded delivery order represents a firm fixed price procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of medications and medical supplies to military healthcare systems and other federal customers. The contract reflects DLA's ongoing pharmaceutical procurement strategy supporting the Defense Health Agency and broader military medical supply chains through established prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |